lifestyle.side.cr

Author: Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.

Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution

April 28, 2026
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework

April 28, 2026
Fosun Pharma Announces 2025 Annual Results

March 24, 2026
Fosun Pharma’s Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

December 9, 2025